Navigation Links
Food science expert: Genetically modified crops are overregulated
Date:2/17/2013

CHAMPAIGN, Ill. It has been almost 20 years since the first genetically modified foods showed up in produce aisles throughout the United States and the rest of the world, but controversy continues to surround the products and their regulation.

Bruce Chassy, a professor emeritus of food science and human nutrition at the University of Illinois at Urbana-Champaign, believes that after thousands of research studies and worldwide planting, "genetically modified foods pose no special risks to consumers or the environment" and are overregulated.

Chassy will elaborate on this conclusion at the 2013 meeting of the American Association for the Advancement of Science in Boston on Feb. 17. During his talk, "Regulating the Safety of Foods and Feeds Derived From Genetically Modified Crops," Chassy will share his view that the overregulation of GM crops actually hurts the environment, reduces global health and burdens the consumer.

Farmers have witnessed the advantages of GM crops firsthand through increases in their yields and profit, and decreases in their labor, energy consumption, pesticide use and greenhouse gas emissions, Chassy said.

Despite these benefits, various regulatory agencies require newly developed GM crops to be put to the test with rigorous safety evaluations that include molecular characterization, toxicological evaluation, allergenicity assessments, compositional analysis and feeding studies. This extensive testing takes five to 10 years and costs tens of millions of dollars, and Chassy argues that this process "wastes resources and diverts attention from real food safety issues."

"With more than half of the world's population now living in countries that have adopted GM crops, it might be appropriate to reduce the regulatory scrutiny of GM crops to a level that is commensurate with science-based risk assessment," Chassy said.

During his talk, Chassy will chronicle the scientific tests used in pre-market safety assessments of GM foods and elaborate on the evidence from thousands of research studies and expansive GM plantings that he says show these crops do not present risks to consumers or the environment. The overregulation of GM foods is a response not to scientific evidence, Chassy said, but to a global campaign that disseminates misinformation and fear about these food sources.


'/>"/>
Contact: Chelsey B. Coombs
diya@illinois.edu
217-333-5802
University of Illinois at Urbana-Champaign
Source:Eurekalert  

Related biology technology :

1. Bayer CropScience Innovation Plus Platform Offers Customizable Tools
2. Research article coauthored by Pitt professor named best article of the year by Science
3. Chicago to Welcome Data Science, Big Data and Data Mining Leaders at the 19th International ACM Knowledge Discovery and Data Mining Conference, KDD 2013
4. Up to the Challenge: Careers in Science in the Midst of Drastic Change, According to Wysebridge Patent Bar Review
5. Charm Sciences EZ System Accepted for Antibiotic Testing of Raw Milk in the US NCIMS Residue Screening Program
6. Latest Environmental Research Featured at ScienceAlerts.com
7. Nano3D Biosciences Releases 96-well BioAssembler for 3D Cell Culture
8. Industry Executives to Explore the Future of Life Sciences Research Powered By Big Data Analytics
9. New Product Launch: Are your Strategies for Emerging Healthcare and Life Sciences Markets Innovative and Structured?
10. Seeing is Believing for Growers at Bayer CropScience Respect the Rotation Events
11. Taylor-Wharton CryoScience 'Partners For Life' Awards Liquid Nitrogen Freezer to Comprehensive Cancer Center at University of Alabama at Birmingham
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Food science expert: Genetically modified crops are overregulated
(Date:2/17/2017)... February 17, 2017 According ... by Product (Consumables, Service), Type (Safety, Efficacy, Validation), ... Drug Discovery and Development, Disease-Risk) - Global Forecast ... projected to reach USD 53.34 Billion by 2021 ... a CAGR of 13.8% during the forecast period ...
(Date:2/17/2017)... Feb. 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... its oral peptide drug candidates, PTG-100 and PTG-200, ... European Crohn,s and Colitis Organization (ECCO).  The ECCO ... Spain from February 15 – 18, ... data on Protagonist drug candidates PTG-100 and PTG-200. ...
(Date:2/16/2017)... and GREENWICH, Conn. ... private investment firm focused on venture growth investments ... promotion of Josh Richardson , M.D. to ... investments in biotechnology companies.  He is a board ... important roles in Longitude,s investments in Aimmune Therapeutics, ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor ... a clinical-stage biotechnology company developing first-in-class biological therapies ... that it has elected to terminate its license ... peptide receptor agonists, including Cenderitide. "Our ... move as we prioritize our efforts to advance ...
Breaking Biology Technology:
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
(Date:2/9/2017)... Feb. 9, 2017 The biomass boiler market ... the biomass boiler market globally in terms of revenue ... boilers. The market for biomass boilers has been segmented ... application, and country/region. The market based on feedstock type, ... residues, biogas & energy crops, urban residues, and others. ...
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
Breaking Biology News(10 mins):